RUNX2 and congenital bilateral aplasia of vas deferens from CFTR mutation: Wnt signaling enhances both RUNX2 expression and ALP activity (38), and several of its key components—including the receptor LRP5, the agonist WNT3a, and the nuclear effector β-catenin—are overexpressed in CAVD samples (39).